무스카린성 아세틸콜린 M1 수용체 길항제의 결정질 화합물

본 명세서에는, 특히, mAChR M1 길항제의 결정질 화합물, 그의 약제학적 조성물, 및 치료 방법이 개시된다. Disclosed herein, inter alia, are a crystalline compound of mAChR M1 antagonist, its pharmaceutical composition and methods of treatment.

Saved in:
Bibliographic Details
Main Authors XIONG YIFENG, BRAVO YALDA, ROPPE JEFFREY, CHEN AUSTIN CHIH YU, BACCEI JILL MELISSA, SCHRADER THOMAS
Format Patent
LanguageKorean
Published 19.12.2023
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract 본 명세서에는, 특히, mAChR M1 길항제의 결정질 화합물, 그의 약제학적 조성물, 및 치료 방법이 개시된다. Disclosed herein, inter alia, are a crystalline compound of mAChR M1 antagonist, its pharmaceutical composition and methods of treatment.
AbstractList 본 명세서에는, 특히, mAChR M1 길항제의 결정질 화합물, 그의 약제학적 조성물, 및 치료 방법이 개시된다. Disclosed herein, inter alia, are a crystalline compound of mAChR M1 antagonist, its pharmaceutical composition and methods of treatment.
Author ROPPE JEFFREY
CHEN AUSTIN CHIH YU
SCHRADER THOMAS
BRAVO YALDA
BACCEI JILL MELISSA
XIONG YIFENG
Author_xml – fullname: XIONG YIFENG
– fullname: BRAVO YALDA
– fullname: ROPPE JEFFREY
– fullname: CHEN AUSTIN CHIH YU
– fullname: BACCEI JILL MELISSA
– fullname: SCHRADER THOMAS
BookMark eNrjYmDJy89L5WTwfb1my5uuJW92bnm9bMOblo0Kb6a2vGnZ8bZ7x5u9c4BCCr6GCm86ZryZtfLNpi0Kr3bseDt17ZsFc97MnaHwatOGNwumvlneofB25pS3U1e-XrOHh4E1LTGnOJUXSnMzKLu5hjh76KYW5MenFhckJqfmpZbEewcZGRgZGxiaG1gamzsaE6cKAJujT5I
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID KR20230170937A
GroupedDBID EVB
ID FETCH-epo_espacenet_KR20230170937A3
IEDL.DBID EVB
IngestDate Fri Jul 19 12:45:31 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Korean
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_KR20230170937A3
Notes Application Number: KR20237038569
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231219&DB=EPODOC&CC=KR&NR=20230170937A
ParticipantIDs epo_espacenet_KR20230170937A
PublicationCentury 2000
PublicationDate 20231219
PublicationDateYYYYMMDD 2023-12-19
PublicationDate_xml – month: 12
  year: 2023
  text: 20231219
  day: 19
PublicationDecade 2020
PublicationYear 2023
RelatedCompanies PIPELINE THERAPEUTICS, INC
RelatedCompanies_xml – name: PIPELINE THERAPEUTICS, INC
Score 3.4886522
Snippet 본 명세서에는, 특히, mAChR M1 길항제의 결정질 화합물, 그의 약제학적 조성물, 및 치료 방법이 개시된다. Disclosed herein, inter alia, are a crystalline compound of mAChR M1 antagonist, its...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title 무스카린성 아세틸콜린 M1 수용체 길항제의 결정질 화합물
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231219&DB=EPODOC&locale=&CC=KR&NR=20230170937A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSTE3N0tJTDEDttxSzXVNzNMMdBMtTFJ1k8xTzFOTTEwtkxJBA_q-fmYeoSZeEaYRTAw5sL0w4HNCy8GHIwJzVDIwv5eAy-sCxCCWC3htZbF-UiZQKN_eLcTWRQ3aOwY2VkA50MXJ1jXA38XfWc3Z2dY7SM0vCCwHOioGWBs7MjOwghrSoJP2XcOcQPtSCpArFTdBBrYAoHl5JUIMTNn5wgyczrC714QZOHyhU95AJjT3FYsw-L5es-VN15I3O7e8XrbhTctGhTdTW9607HjbvePN3jlAIQVfQ4U3HTPezFr5ZtMWhVc7dryduvbNgjlv5s5QeLVpw5sFU98s71B4O3PK26krX6_ZI8qg7OYa4uyhC3RXPDwY4r2DkD1hLMbAkpeflyrBoGCRamGUZJJsmWKYaAkM3cQk0FSdcZp5CjDUTY1NzCUZZPCZJIVfWpqBC8QFLeEwtJRhYCkpKk2VBVbEJUly4PADAK3ro7I
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSTE3N0tJTDEDttxSzXVNzNMMdBMtTFJ1k8xTzFOTTEwtkxJBA_q-fmYeoSZeEaYRTAw5sL0w4HNCy8GHIwJzVDIwv5eAy-sCxCCWC3htZbF-UiZQKN_eLcTWRQ3aOwY2VkA50MXJ1jXA38XfWc3Z2dY7SM0vCCwHOioGWBs7MjOwmoPO5wU1nsKcQPtSCpArFTdBBrYAoHl5JUIMTNn5wgyczrC714QZOHyhU95AJjT3FYsw-L5es-VN15I3O7e8XrbhTctGhTdTW9607HjbvePN3jlAIQVfQ4U3HTPezFr5ZtMWhVc7dryduvbNgjlv5s5QeLVpw5sFU98s71B4O3PK26krX6_ZI8qg7OYa4uyhC3RXPDwY4r2DkD1hLMbAkpeflyrBoGCRamGUZJJsmWKYaAkM3cQk0FSdcZp5CjDUTY1NzCUZZPCZJIVfWp6B0yPE1yfex9PPW5qBCyQFWs5haCnDwFJSVJoqC6yUS5LkwGEJAH9gpp8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=%EB%AC%B4%EC%8A%A4%EC%B9%B4%EB%A6%B0%EC%84%B1+%EC%95%84%EC%84%B8%ED%8B%B8%EC%BD%9C%EB%A6%B0+M1+%EC%88%98%EC%9A%A9%EC%B2%B4+%EA%B8%B8%ED%95%AD%EC%A0%9C%EC%9D%98+%EA%B2%B0%EC%A0%95%EC%A7%88+%ED%99%94%ED%95%A9%EB%AC%BC&rft.inventor=XIONG+YIFENG&rft.inventor=BRAVO+YALDA&rft.inventor=ROPPE+JEFFREY&rft.inventor=CHEN+AUSTIN+CHIH+YU&rft.inventor=BACCEI+JILL+MELISSA&rft.inventor=SCHRADER+THOMAS&rft.date=2023-12-19&rft.externalDBID=A&rft.externalDocID=KR20230170937A